These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7994070)

  • 1. Improving patient outcomes in a dialysis unit: an integrated approach to CQI.
    Heard K
    J Nurs Care Qual; 1994 Oct; 9(1):44-50. PubMed ID: 7994070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving clinical processes: one dialysis facility's experiences.
    Bennett J; Cranford W; Staples B; Hartline P; Blondin J; Harter H; Rutherford WE
    Qual Manag Health Care; 1997; 6(1):45-60. PubMed ID: 10176408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementing continuous quality improvement strategies for improving iron replacement in hemodialysis patients.
    Trenkle JA
    Nephrol Nurs J; 2001 Oct; 28(5):561-5. PubMed ID: 12143432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous quality improvement: at the grassroots.
    Bogdanski P; Locking-Cusolito H
    CANNT J; 2001; 11(4):44-7. PubMed ID: 11885348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in dialysis units' quality improvement practices from 1994 to 1996.
    Frederick PR; Frankenfield DL; Biddle MG; Sims TW
    ANNA J; 1998 Oct; 25(5):469-78. PubMed ID: 9887699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Categorizing the response to Epoetin alfa therapy. Case study of the anemic patient.
    Watson C
    ANNA J; 1999 Dec; 26(6):629-32. PubMed ID: 10876477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin B(6) therapy does not improve hematocrit in hemodialysis patients supplemented with iron and erythropoietin.
    Weissgarten J; Modai D; Oz D; Chen Levy Z; Cohn M; Marcus O; Dishi V; Galperin E; Averbukh Z
    Nephron; 2001 Apr; 87(4):328-32. PubMed ID: 11287776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the management of anemia in hemodialysis patients by implementing the continuous quality improvement program.
    Chen M; Deng JH; Zhou FD; Wang M; Wang HY
    Blood Purif; 2006; 24(3):282-6. PubMed ID: 16462138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An educational tool for the care of the hemodialysis patient admitted to an acute care hospital.
    Deschenes D
    CANNT J; 2001; 11(4):24-9; quiz 30-2, 35-41; quiz 41--3. PubMed ID: 11885347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CQI in action: benefiting our patients.
    Quirk BP
    ANNA J; 1994 Oct; 21(6):341-5. PubMed ID: 7993139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should the hematocrit (hemoglobin) be normalized in Pre-ESRD or dialysis patients? Yes!
    Besarab A; Aslam M
    Blood Purif; 2001; 19(2):168-74. PubMed ID: 11150804
    [No Abstract]   [Full Text] [Related]  

  • 12. CQI and anemia management: maximizing positive outcomes. Case study of the anemic patient.
    Burrows-Hudson S
    ANNA J; 1997 Apr; 24(2):254-60; quiz 261. PubMed ID: 9180430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should the hematocrit be normalized in dialysis and in pre-ESRD patients?
    Macdougall IC
    Blood Purif; 2001; 19(2):157-67. PubMed ID: 11150803
    [No Abstract]   [Full Text] [Related]  

  • 14. Nutritional status: a continuous quality improvement approach.
    Blondin J; Ryan C
    Am J Kidney Dis; 1999 Jan; 33(1):198-202. PubMed ID: 9915291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of captopril-bound Fe by end-stage renal failure patients during hemodialysis.
    Averbukh Z; Berman S; Kishinevsky E; Feldman L; Cohn M; Rapoport M; Galperin E; Dishi V; Weissgarten J
    J Nephrol; 2004; 17(1):101-6. PubMed ID: 15151265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis between centrifuged hematocrit and "point-of-care" hemoglobin: impact on erythropoietin dosing.
    Marooney M
    ANNA J; 1998 Oct; 25(5):479-81. PubMed ID: 9887700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients].
    Jalil R; Vaccarezza A; Jara A; Lira P; Vial S; Serrano V
    Rev Med Chil; 1990 Jun; 118(6):629-34. PubMed ID: 1775783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A practical approach to TQI.
    Perras ST; Mattern M
    ANNA J; 1994 Apr; 21(2):129-36, 143. PubMed ID: 8080313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of rHuEPO resistance in CRF patients: a clinical protocol at Winthrop-University Hospital.
    Trenkle JA
    ANNA J; 1998 Jun; 25(3):333-8, 344. PubMed ID: 9801489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodialysis in a satellite unit: clinical performance target attainment and health-related quality of life.
    Diamant MJ; Young A; Gallo K; Xi W; Suri RS; Garg AX; Moist LM
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1692-9. PubMed ID: 21566106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.